Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology

HIV is now a chronic infection as patients with access to antiretroviral therapy have
significantly improved life expectancies. Patients with HIV also have an increased risk of
cardiovascular disease. Thus, cardiovascular disease is an important potential co-morbidity
for patients living with HIV. The current proposal will perform a detailed cardiovascular
assessment using state-of-the-art imaging techniques to evaluate intramyocardial lipid as
well as coronary artery disease and myocardial function in a cohort of 100 HIV infected
patients and 30 healthy volunteers as controls. This is an early exploratory cross-sectional
study designed to both assess the burden of disease and apply novel techniques in this unique
population.

- HIV-Infected Participants Criteria:

INCLUSION CRITERIA:

1. Age 18 years or greater

2. Documented HIV infection

3. Willingness to have stored samples

EXCLUSION CRITERIA:

1. Subject is deemed unable to comply with requirements of study participation.

2. Subjects with contraindication to MRI scanning. These contraindications include but
are not limited to the following devices or conditions:

- Implanted cardiac pacemaker or defibrillator

- Cochlear implants

- Ocular foreign body (e.g. metal shavings)

- Embedded shrapnel fragments

- Central nervous system aneurysm clips

- Implanted neural stimulator

- Medical infusion pumps

- Any implanted device that is incompatible with MRI.

3. Subjects requiring sedation for MRI studies.

4. Subjects with a condition precluding entry into scanner and acquisition of scans (e.g.
morbid obesity, claustrophobia, back pain, motion disorders).

5. Women who are lactating, pregnant, or actively seeking to become pregnant.

6. History of severe allergic reaction to gadolinium contrast agents despite the use of
premedication with an anti-histaminic and cortisone.

7. Estimated glomerular filtration rate (eGFR) <60 cc/min/1.73m(2).

8. Creatinine value >3.0 mg/dl

For Coronary CTA with Iodine-Based Contrast*:

1. Contraindication to the use of CT contrast agents:

- Creatinine value >1.4 mg/dl or eGFR <60 cc/min/1.73m(2).

- History of multiple myeloma

- Use of metformin-containing products less than 24 hrs prior to contrast
administration

- History of significant allergic reaction to CT contrast agents

2. Subjects with contraindication precluding the use of beta blockers necessary to
perform the coronary CTA. These include:

- Clinically significant asthma

- Active bronchospasm

- Moderate or severe chronic obstructive pulmonary disease (COPD)

- 2nd or 3rd degree AV block

- Decompensated cardiac failure

- Allergy to beta blockers

- Systolic blood pressure <100 mm Hg

3. Guidelines for use of beta blocker is outlined in Appendix 1.

- Participants who are eligible for MRI but who are not eligible for cardiac CT
scan will be allowed to participate in the non-CT portion of the study.

Healthy Control Criteria:

INCLUSION CRITERIA:

1. Age 18 years or greater

2. Willingness to have stored samples

EXCLUSION CRITERIA:

All of the exclusion criteria for HIV-infected participants listed above apply to healthy
controls. In addition, the following exclusion criteria will also be applied to healthy
controls:

1. Clinically significant, systemic illness (serious infections or significant cardiac,
pulmonary, hepatic, or other organ dysfunction) which in the judgment of the
investigators would compromise the patient s ability to tolerate this study.

2. History of or current known cardiovascular disease.

3. HIV infection.